Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Price:
42.3 USD
-0.26%
Market Closed
Updated:
May 12, 2024
Taro Pharmaceutical Industries Ltd
Tax Provision
|
Taro Pharmaceutical Industries Ltd
Tax Provision Peer Comparison
Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Tax Provision
-$28.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Tax Provision
$7m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-17%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Tax Provision
₪12m
|
CAGR 3-Years
1 717%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Tax Provision
-$185k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Tax Provision
-₪1.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's Tax Provision?
Tax Provision
-28.6m
USD
-28.6m
USD
Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Tax Provision amounts to -28.6m USD.
What is Taro Pharmaceutical Industries Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
10%
10%
The average annual Tax Provision growth rates for Taro Pharmaceutical Industries Ltd have been 4% over the past three years , 16% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
